APO Research

APO RESEARCH · REPORT

Enalapril

Selected research

Market Structure

Global Enalapril Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Enalapril market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Enalapril is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enalapril include Wockhardt Americas Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa Inc, Teva Parenteral Medicines Inc, Taro Pharmaceutical Industries Ltd, Sandoz Inc, Ranbaxy Laboratories Ltd, Mylan Pharmaceuticals Inc and Lek Pharmaceuticals D D, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enalapril market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enalapril and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enalapril sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enalapril market size, projected growth trends, production technologies, key applications, and end-use industries.

Enalapril Segment by Company

Wockhardt Americas Inc

Watson Laboratories Inc

Teva Pharmaceuticals Usa Inc

Teva Parenteral Medicines Inc

Taro Pharmaceutical Industries Ltd

Sandoz Inc

Ranbaxy Laboratories Ltd

Mylan Pharmaceuticals Inc

Lek Pharmaceuticals D D

Krka Dd Novo Mesto

Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa

Hospira Inc

Hikma Farmaceutica (Portugal) Sa

Biovail Laboratories International Srl

Bedford Laboratories Div Ben Venue Laboratories Inc

Apothecon Inc Div Bristol Myers Squibb

Apotex Inc

Enalapril Segment by Type

10mg

2.5mg

20mg

5mg

Enalapril Segment by Application

Hospital

Drugs Store

Enalapril Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enalapril market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enalapril and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enalapril.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enalapril market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enalapril manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Enalapril in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Enalapril Industry Trends Table 2. Enalapril Industry Drivers Table 3. Enalapril Industry Opportunities and Challenges Table 4. Enalapril Industry Restraints Table 5. Global Enalapril Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Enalapril Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Enalapril Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Enalapril Sales Market Share by Manufacturers Table 9. Global Enalapril Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Enalapril Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Enalapril Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Enalapril Manufacturers, Product Type & Application Table 13. Global Enalapril Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Enalapril by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg Table 17. Major Manufacturers of 2.5mg Table 18. Major Manufacturers of 20mg Table 19. Major Manufacturers of 5mg Table 20. Global Enalapril Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Enalapril Sales by Type (2021-2026) & (K Units) Table 22. Global Enalapril Sales by Type (2027-2032) & (K Units) Table 23. Global Enalapril Sales Market Share by Type (2021-2026) Table 24. Global Enalapril Sales Market Share by Type (2027-2032) Table 25. Global Enalapril Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Enalapril Revenue by Type (2021-2026) & (K Units) Table 27. Global Enalapril Revenue by Type (2027-2032) & (K Units) Table 28. Global Enalapril Revenue Market Share by Type (2021-2026) Table 29. Global Enalapril Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Drugs Store Table 32. Global Enalapril Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Enalapril Sales by Application (2021-2026) & (K Units) Table 34. Global Enalapril Sales by Application (2027-2032) & (K Units) Table 35. Global Enalapril Sales Market Share by Application (2021-2026) Table 36. Global Enalapril Sales Market Share by Application (2027-2032) Table 37. Global Enalapril Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Enalapril Revenue by Application (2021-2026) & (K Units) Table 39. Global Enalapril Revenue by Application (2027-2032) & (K Units) Table 40. Global Enalapril Revenue Market Share by Application (2021-2026) Table 41. Global Enalapril Revenue Market Share by Application (2027-2032) Table 42. Global Enalapril Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Enalapril Sales by Region (2021-2026) & (K Units) Table 44. Global Enalapril Sales Market Share by Region (2021-2026) Table 45. Global Enalapril Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Enalapril Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Enalapril Sales by Country (2021-2026) & (K Units) Table 49. North America Enalapril Sales by Country (2027-2032) & (K Units) Table 50. Europe Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Enalapril Sales by Country (2021-2026) & (K Units) Table 52. Europe Enalapril Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Enalapril Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Enalapril Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Enalapril Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Enalapril Sales by Country (2027-2032) & (K Units) Table 59. Global Enalapril Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Enalapril Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Enalapril Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Enalapril Revenue Market Share by Region (2021-2026) Table 63. Global Enalapril Revenue Market Share by Region (2027-2032) Table 64. Wockhardt Americas Inc Company Information Table 65. Wockhardt Americas Inc Business Overview Table 66. Wockhardt Americas Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Wockhardt Americas Inc Enalapril Product Portfolio Table 68. Wockhardt Americas Inc Recent Development Table 69. Watson Laboratories Inc Company Information Table 70. Watson Laboratories Inc Business Overview Table 71. Watson Laboratories Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Watson Laboratories Inc Enalapril Product Portfolio Table 73. Watson Laboratories Inc Recent Development Table 74. Teva Pharmaceuticals Usa Inc Company Information Table 75. Teva Pharmaceuticals Usa Inc Business Overview Table 76. Teva Pharmaceuticals Usa Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio Table 78. Teva Pharmaceuticals Usa Inc Recent Development Table 79. Teva Parenteral Medicines Inc Company Information Table 80. Teva Parenteral Medicines Inc Business Overview Table 81. Teva Parenteral Medicines Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Teva Parenteral Medicines Inc Enalapril Product Portfolio Table 83. Teva Parenteral Medicines Inc Recent Development Table 84. Taro Pharmaceutical Industries Ltd Company Information Table 85. Taro Pharmaceutical Industries Ltd Business Overview Table 86. Taro Pharmaceutical Industries Ltd Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio Table 88. Taro Pharmaceutical Industries Ltd Recent Development Table 89. Sandoz Inc Company Information Table 90. Sandoz Inc Business Overview Table 91. Sandoz Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sandoz Inc Enalapril Product Portfolio Table 93. Sandoz Inc Recent Development Table 94. Ranbaxy Laboratories Ltd Company Information Table 95. Ranbaxy Laboratories Ltd Business Overview Table 96. Ranbaxy Laboratories Ltd Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Ranbaxy Laboratories Ltd Enalapril Product Portfolio Table 98. Ranbaxy Laboratories Ltd Recent Development Table 99. Mylan Pharmaceuticals Inc Company Information Table 100. Mylan Pharmaceuticals Inc Business Overview Table 101. Mylan Pharmaceuticals Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Mylan Pharmaceuticals Inc Enalapril Product Portfolio Table 103. Mylan Pharmaceuticals Inc Recent Development Table 104. Lek Pharmaceuticals D D Company Information Table 105. Lek Pharmaceuticals D D Business Overview Table 106. Lek Pharmaceuticals D D Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Lek Pharmaceuticals D D Enalapril Product Portfolio Table 108. Lek Pharmaceuticals D D Recent Development Table 109. Krka Dd Novo Mesto Company Information Table 110. Krka Dd Novo Mesto Business Overview Table 111. Krka Dd Novo Mesto Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Krka Dd Novo Mesto Enalapril Product Portfolio Table 113. Krka Dd Novo Mesto Recent Development Table 114. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information Table 115. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview Table 116. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio Table 118. Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Development Table 119. Hospira Inc Company Information Table 120. Hospira Inc Business Overview Table 121. Hospira Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hospira Inc Enalapril Product Portfolio Table 123. Hospira Inc Recent Development Table 124. Hikma Farmaceutica (Portugal) Sa Company Information Table 125. Hikma Farmaceutica (Portugal) Sa Business Overview Table 126. Hikma Farmaceutica (Portugal) Sa Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio Table 128. Hikma Farmaceutica (Portugal) Sa Recent Development Table 129. Biovail Laboratories International Srl Company Information Table 130. Biovail Laboratories International Srl Business Overview Table 131. Biovail Laboratories International Srl Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Biovail Laboratories International Srl Enalapril Product Portfolio Table 133. Biovail Laboratories International Srl Recent Development Table 134. Bedford Laboratories Div Ben Venue Laboratories Inc Company Information Table 135. Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview Table 136. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio Table 138. Bedford Laboratories Div Ben Venue Laboratories Inc Recent Development Table 139. Apothecon Inc Div Bristol Myers Squibb Company Information Table 140. Apothecon Inc Div Bristol Myers Squibb Business Overview Table 141. Apothecon Inc Div Bristol Myers Squibb Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio Table 143. Apothecon Inc Div Bristol Myers Squibb Recent Development Table 144. Apotex Inc Company Information Table 145. Apotex Inc Business Overview Table 146. Apotex Inc Enalapril Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Apotex Inc Enalapril Product Portfolio Table 148. Apotex Inc Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Enalapril Distributors List Table 152. Enalapril Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Enalapril Product Image Figure 2. Global Enalapril Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enalapril Market Size (2021-2032) & (US$ Million) Figure 4. Global Enalapril Sales (2021-2032) & (K Units) Figure 5. Global Enalapril Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Enalapril Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg Image Figure 9. 2.5mg Image Figure 10. 20mg Image Figure 11. 5mg Image Figure 12. Global Enalapril Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Enalapril Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Enalapril Sales Market Share by Type (2021-2032) Figure 15. Global Enalapril Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Enalapril Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Enalapril Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drugs Store Image Figure 20. Global Enalapril Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Enalapril Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Enalapril Sales Market Share by Application (2021-2032) Figure 23. Global Enalapril Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Enalapril Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Enalapril Revenue Market Share by Application (2021-2032) Figure 26. North America Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Enalapril Sales Market Share by Country (2021-2032) Figure 28. U.S. Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Enalapril Sales Market Share by Country (2021-2032) Figure 33. Germany Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Enalapril Sales Market Share by Country (2021-2032) Figure 40. China Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Enalapril Sales Market Share by Country (2021-2032) Figure 48. Brazil Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Enalapril Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Enalapril Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Enalapril Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Enalapril Revenue (2021-2032) & (US$ Million) Figure 59. North America Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Enalapril Revenue (2021-2032) & (US$ Million) Figure 61. Europe Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Enalapril Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Enalapril Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Enalapril Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Enalapril Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 2.5mg
  • 20mg
  • 5mg
Applications
  • Hospital
  • Drugs Store
Companies covered
  • Wockhardt Americas Inc
  • Watson Laboratories Inc
  • Teva Pharmaceuticals Usa Inc
  • Teva Parenteral Medicines Inc
  • Taro Pharmaceutical Industries Ltd
  • Sandoz Inc
  • Ranbaxy Laboratories Ltd
  • Mylan Pharmaceuticals Inc
  • Lek Pharmaceuticals D D
  • Krka Dd Novo Mesto
  • Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  • Hospira Inc
  • Hikma Farmaceutica (Portugal) Sa
  • Biovail Laboratories International Srl
  • Bedford Laboratories Div Ben Venue Laboratories Inc
  • Apothecon Inc Div Bristol Myers Squibb
  • Apotex Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enalapril Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enalapril Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Enalapril Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Enalapril Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Enalapril Market Dynamics
  1. 2.1 Enalapril Industry Trends
  2. 2.2 Enalapril Industry Drivers
  3. 2.3 Enalapril Industry Opportunities and Challenges
  4. 2.4 Enalapril Industry Restraints
3 Enalapril Market by Manufacturers
  1. 3.1 Global Enalapril Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Enalapril Sales by Manufacturers (2021-2026)
  3. 3.3 Global Enalapril Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Enalapril Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enalapril Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Enalapril Manufacturers, Product Type & Application
  7. 3.7 Global Enalapril Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enalapril Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enalapril Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enalapril Tier 1, Tier 2, and Tier 3
4 Enalapril Market by Type
  1. 4.1 Enalapril Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 2.5mg
  4. 4.1.3 20mg
  5. 4.1.4 5mg
  6. 4.2 Global Enalapril Sales by Type
  7. 4.2.1 Global Enalapril Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Enalapril Sales by Type (2021-2032)
  9. 4.2.3 Global Enalapril Sales Market Share by Type (2021-2032)
  10. 4.3 Global Enalapril Revenue by Type
  11. 4.3.1 Global Enalapril Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Enalapril Revenue by Type (2021-2032)
  13. 4.3.3 Global Enalapril Revenue Market Share by Type (2021-2032)
5 Enalapril Market by Application
  1. 5.1 Enalapril Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Enalapril Sales by Application
  5. 5.2.1 Global Enalapril Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Enalapril Sales by Application (2021-2032)
  7. 5.2.3 Global Enalapril Sales Market Share by Application (2021-2032)
  8. 5.3 Global Enalapril Revenue by Application
  9. 5.3.1 Global Enalapril Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Enalapril Revenue by Application (2021-2032)
  11. 5.3.3 Global Enalapril Revenue Market Share by Application (2021-2032)
6 Global Enalapril Sales by Region
  1. 6.1 Global Enalapril Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enalapril Sales by Region (2021-2032)
  3. 6.2.1 Global Enalapril Sales by Region (2021-2026)
  4. 6.2.2 Global Enalapril Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Enalapril Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Enalapril Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Enalapril Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Enalapril Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Enalapril Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Enalapril Revenue by Region
  1. 7.1 Global Enalapril Revenue by Region
  2. 7.1.1 Global Enalapril Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Enalapril Revenue by Region (2021-2026)
  4. 7.1.3 Global Enalapril Revenue by Region (2027-2032)
  5. 7.1.4 Global Enalapril Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Enalapril Revenue (2021-2032)
  8. 7.2.2 North America Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Enalapril Revenue (2021-2032)
  11. 7.3.2 Europe Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Enalapril Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Enalapril Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Enalapril Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wockhardt Americas Inc
  2. 8.1.1 Wockhardt Americas Inc Company Information
  3. 8.1.2 Wockhardt Americas Inc Business Overview
  4. 8.1.3 Wockhardt Americas Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wockhardt Americas Inc Enalapril Product Portfolio
  6. 8.1.5 Wockhardt Americas Inc Recent Developments
  7. 8.2 Watson Laboratories Inc
  8. 8.2.1 Watson Laboratories Inc Company Information
  9. 8.2.2 Watson Laboratories Inc Business Overview
  10. 8.2.3 Watson Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Watson Laboratories Inc Enalapril Product Portfolio
  12. 8.2.5 Watson Laboratories Inc Recent Developments
  13. 8.3 Teva Pharmaceuticals Usa Inc
  14. 8.3.1 Teva Pharmaceuticals Usa Inc Company Information
  15. 8.3.2 Teva Pharmaceuticals Usa Inc Business Overview
  16. 8.3.3 Teva Pharmaceuticals Usa Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceuticals Usa Inc Enalapril Product Portfolio
  18. 8.3.5 Teva Pharmaceuticals Usa Inc Recent Developments
  19. 8.4 Teva Parenteral Medicines Inc
  20. 8.4.1 Teva Parenteral Medicines Inc Company Information
  21. 8.4.2 Teva Parenteral Medicines Inc Business Overview
  22. 8.4.3 Teva Parenteral Medicines Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Parenteral Medicines Inc Enalapril Product Portfolio
  24. 8.4.5 Teva Parenteral Medicines Inc Recent Developments
  25. 8.5 Taro Pharmaceutical Industries Ltd
  26. 8.5.1 Taro Pharmaceutical Industries Ltd Company Information
  27. 8.5.2 Taro Pharmaceutical Industries Ltd Business Overview
  28. 8.5.3 Taro Pharmaceutical Industries Ltd Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Taro Pharmaceutical Industries Ltd Enalapril Product Portfolio
  30. 8.5.5 Taro Pharmaceutical Industries Ltd Recent Developments
  31. 8.6 Sandoz Inc
  32. 8.6.1 Sandoz Inc Company Information
  33. 8.6.2 Sandoz Inc Business Overview
  34. 8.6.3 Sandoz Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz Inc Enalapril Product Portfolio
  36. 8.6.5 Sandoz Inc Recent Developments
  37. 8.7 Ranbaxy Laboratories Ltd
  38. 8.7.1 Ranbaxy Laboratories Ltd Company Information
  39. 8.7.2 Ranbaxy Laboratories Ltd Business Overview
  40. 8.7.3 Ranbaxy Laboratories Ltd Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ranbaxy Laboratories Ltd Enalapril Product Portfolio
  42. 8.7.5 Ranbaxy Laboratories Ltd Recent Developments
  43. 8.8 Mylan Pharmaceuticals Inc
  44. 8.8.1 Mylan Pharmaceuticals Inc Company Information
  45. 8.8.2 Mylan Pharmaceuticals Inc Business Overview
  46. 8.8.3 Mylan Pharmaceuticals Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Mylan Pharmaceuticals Inc Enalapril Product Portfolio
  48. 8.8.5 Mylan Pharmaceuticals Inc Recent Developments
  49. 8.9 Lek Pharmaceuticals D D
  50. 8.9.1 Lek Pharmaceuticals D D Company Information
  51. 8.9.2 Lek Pharmaceuticals D D Business Overview
  52. 8.9.3 Lek Pharmaceuticals D D Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lek Pharmaceuticals D D Enalapril Product Portfolio
  54. 8.9.5 Lek Pharmaceuticals D D Recent Developments
  55. 8.10 Krka Dd Novo Mesto
  56. 8.10.1 Krka Dd Novo Mesto Company Information
  57. 8.10.2 Krka Dd Novo Mesto Business Overview
  58. 8.10.3 Krka Dd Novo Mesto Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Krka Dd Novo Mesto Enalapril Product Portfolio
  60. 8.10.5 Krka Dd Novo Mesto Recent Developments
  61. 8.11 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
  62. 8.11.1 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Company Information
  63. 8.11.2 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Business Overview
  64. 8.11.3 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Enalapril Product Portfolio
  66. 8.11.5 Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa Recent Developments
  67. 8.12 Hospira Inc
  68. 8.12.1 Hospira Inc Company Information
  69. 8.12.2 Hospira Inc Business Overview
  70. 8.12.3 Hospira Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hospira Inc Enalapril Product Portfolio
  72. 8.12.5 Hospira Inc Recent Developments
  73. 8.13 Hikma Farmaceutica (Portugal) Sa
  74. 8.13.1 Hikma Farmaceutica (Portugal) Sa Company Information
  75. 8.13.2 Hikma Farmaceutica (Portugal) Sa Business Overview
  76. 8.13.3 Hikma Farmaceutica (Portugal) Sa Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Farmaceutica (Portugal) Sa Enalapril Product Portfolio
  78. 8.13.5 Hikma Farmaceutica (Portugal) Sa Recent Developments
  79. 8.14 Biovail Laboratories International Srl
  80. 8.14.1 Biovail Laboratories International Srl Company Information
  81. 8.14.2 Biovail Laboratories International Srl Business Overview
  82. 8.14.3 Biovail Laboratories International Srl Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biovail Laboratories International Srl Enalapril Product Portfolio
  84. 8.14.5 Biovail Laboratories International Srl Recent Developments
  85. 8.15 Bedford Laboratories Div Ben Venue Laboratories Inc
  86. 8.15.1 Bedford Laboratories Div Ben Venue Laboratories Inc Company Information
  87. 8.15.2 Bedford Laboratories Div Ben Venue Laboratories Inc Business Overview
  88. 8.15.3 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Bedford Laboratories Div Ben Venue Laboratories Inc Enalapril Product Portfolio
  90. 8.15.5 Bedford Laboratories Div Ben Venue Laboratories Inc Recent Developments
  91. 8.16 Apothecon Inc Div Bristol Myers Squibb
  92. 8.16.1 Apothecon Inc Div Bristol Myers Squibb Company Information
  93. 8.16.2 Apothecon Inc Div Bristol Myers Squibb Business Overview
  94. 8.16.3 Apothecon Inc Div Bristol Myers Squibb Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Apothecon Inc Div Bristol Myers Squibb Enalapril Product Portfolio
  96. 8.16.5 Apothecon Inc Div Bristol Myers Squibb Recent Developments
  97. 8.17 Apotex Inc
  98. 8.17.1 Apotex Inc Company Information
  99. 8.17.2 Apotex Inc Business Overview
  100. 8.17.3 Apotex Inc Enalapril Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Apotex Inc Enalapril Product Portfolio
  102. 8.17.5 Apotex Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enalapril Value Chain Analysis
  2. 9.1.1 Enalapril Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enalapril Production Mode & Process
  6. 9.2 Enalapril Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enalapril Distributors
  9. 9.2.3 Enalapril Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research